-
APOLLO-BRCA-1: Proteogenomic Analysis of Invasive Breast Tumors in Young (less than 40 years old) vs Older Patients (greater than or equal to 60 years old)
Study
phs003636
-
Childhood Cancer Data Initiative (CCDI): Metastatic Osteosarcoma snMultiome Profiling
Study
phs004490
-
NCTN: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma (RTOG-1010)
Study
phs004237
-
Translational Genomics in Cervical Cancer
Study
phs004441
-
Blockade of TGF Beta Drive Hyper Progression on Small Cell Lung Cancer
Study
phs004200
-
Genome Sequencing of Individuals with PTEN Hamartoma Tumor Syndrome
Study
phs004787
-
Niraparib in Pancreatic Cancer
Study
phs004405
-
MP2PRT: PI3K Pathway Activation and Its Associated Genomic Profile as Predictive Biomarkers of HPV-Related Oropharyngeal Cancer: Evaluation of NRG HN002 and RTOG 1016
Study
phs003089
-
CIDR: Elucidating Epigenetic Mechanisms of Racial/Ethnic Disparities in Pancreatic Cancer
Study
phs003735
-
National Cancer Institute - Population Structure and Natural Selection in the Epidemiology of Burkitt Lymphoma in East African Children and Minors (EMBLEM) study in Uganda
Study
phs001705
-
Childhood Cancer Survivor Study (CCSS)
Study
phs001327
-
Childhood Cancer Data Initiative (CCDI): Comprehensive Genomic Sequencing of Pediatric Cancer Cases (CMRI/KUCC)
Study
phs002529
-
CPTAC Proteogenomic Study
Study
phs001287
-
Integrating Genomic and Transcriptomic Data to Identify Breast Cancer Susceptibility Genes
Study
phs003535
-
National Institute of Environmental Health (NIEHS) Sciences Study of Somatic Mutation Load in Clones of Single Human Cells
Study
phs001182
-
Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Consortium and Pancreatic Cancer Case-Control Consortium (PanScan)
Study
phs000206
-
Kids First: Genomics of Orofacial Cleft Birth Defects in Latin American Families
Study
phs001420
-
Prospective Procurement of Solid Tumor Tissue to Identify Novel Therapeutic Targets
Study
phs001003
-
Stockholm-Tartu Atherosclerosis Reverse Network Engineering Task (STARNET)
Study
phs001203
-
Characterization of Prostate Cancer Organoids
Study
phs001587
-
Human Tumor Atlas Network (HTAN)
Study
phs002371
-
Genomic Predictors of Response to Immune Checkpoint Therapy
Study
phs001493
-
Integrative Tissue Analysis of Men with Prostate Cancer
Study
phs001813
-
Childhood Cancer Data Initiative (CCDI): Feasibility and Clinical Utility of Whole Genome Profiling in Pediatric and Young Adult Cancers
Study
phs002620
-
Childhood Cancer Data Initiative (CCDI): NCI-COG Pediatric MATCH Precision Medicine Clinical Trial
Study
phs002883
-
Childhood Cancer Data Initiative (CCDI): Clonal Evolution During Metastatic Spread in High-Risk Neuroblastoma
Study
phs003111
-
A Genomic Atlas of Systemic Interindividual Epigenetic Variation in Humans (GTEx)
Study
phs001746
-
Whole Exome Sequencing of Chronic Lymphocytic Leukemia
Study
phs000435
-
Metatranscriptomic Sequencing of Biological Samples in Immunocompromised Children
Study
phs001684
-
Kids First and INCLUDE: Down Syndrome, Heart Defects, and Acute Lymphoblastic Leukemia
Study
phs002330
-
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
Study
phs003141
-
Single-Cell RNA-Sequencing of Human Prostatectomy Tissue
Study
phs003480
-
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined with Nivolumab and Ipilimumab for Patients with Resected MMR-p Colorectal and Pancreatic Cancer
Study
phs003425
-
Gabriella Miller Kids First (GMKF) Pediatric Research Program in Susceptibility to Ewing Sarcoma Based on Germline Risk and Familial History of Cancer
Study
phs001228
-
Ghana Breast Health Study
Study
phs002387
-
The Prostate, Lung, Colon, Ovary Screening Trial (PLCO)
Study
phs001286
-
Colon Cancer Family Registry (Colon CFR)
Study
phs002733
-
Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick)
Study
phs003099
-
NCTN: Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome (AAML1531)
Study
phs004081
-
Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA and RNA Sequencing
Study
phs003801
-
DNA-Sequencing of Baseline and Progression Plasma from the Phase III Alliance A031201 Trial
Study
phs003325
-
Genomic Sequencing of Pediatric Rhabdomyosarcoma
Study
phs000720
-
Childhood Cancer Data Initiative (CCDI): Molecular Characterization across Pediatric Brain Tumors and Other Solid and Hematologic Malignancies for Research, Diagnostic, and Precision Medicine
Study
phs002517
-
The Cancer Dependency Map (DepMap)
Study
phs003444
-
Integrated Somatic and Germline Molecular Properties Dictating Biological and Clinical Phenotypes in Cancer
Study
phs003438
-
Exome Recapture and Sequencing of Prospectively Characterized Clinical Specimens From Cancer Patients
Study
phs001783
-
A Personalized Neoantigen Vaccine Generates Anti-Tumor Immunity in High-Risk Renal Cell Carcinoma
Study
phs003710
-
Genetic Studies of Homologous Recombination Deficiency in Hispanic Gastric Cancer
Study
phs003251
-
Gene Expression Study of Individuals with Sex Chromosome Aneuploidies
Study
phs002481
-
A Phase II Study: CRS207/GVAX Plus Anti-PD1 and Anti-CTLA4 Recruits Mesothelin- and KRAS-Specific T cells into PDAC
Study
phs003798
-
Childhood Cancer Data Initiative (CCDI): Molecular Characterization Initiative
Study
phs002790
-
Rearrangements of Viral and Human Genomes at Human Papillomavirus Integration Events and Their Allele-Specific Impacts on Cancer Genome Regulation
Study
phs003780
-
Genetic Susceptibility and Biomarkers of Platinum-Related Toxicities
Study
phs001621
-
Integrative Somatic and Germline Molecular Characterization of Genitourinary Cancers
Study
phs002065
-
Natural Killer Cell and Lymphocyte-Targeted Immunotherapies in Cancer
Study
phs002681
-
Genetic analysis of paired diagnosis and relapse neuroblastomas
Study
EGAS50000002000
-
BioKey: T cell Trafficking and Expansion as Early Indicators of Sustained Clinical Response to Immune Checkpoint Blockade
Study
EGAS50000002113
-
PBMCs Bellini TNBC anti-PD1 monotherapy
Study
EGAS50000002067
-
Multi-omics datasets (WES, RNA-seq) of mesothelioma MIST3 study, a phase IIA AXL/PD1 inhibition clinical trial
Study
EGAS50000001704
-
Spatial Profiling Uncovers a High-Risk Stromal-Fibrotic Subtype in Hormone Receptor-Positive, HER2-Negative Breast Cancer
Study
EGAS50000002228
-
IMMUcan NSCLC cohort
Study
EGAS50000001899
-
IMMUcan RCC cohort
Study
EGAS50000002028
-
IMMUcan UroCCR RCC cohort
Study
EGAS50000002049
-
IMMUcan Nirvana NSCLC4 cohort
Study
EGAS50000002115
-
IMMUcan SCCHN2 cohort
Study
EGAS50000002147
-
IMMUcan CRC1 cohort
Study
EGAS50000002159
-
IMMUcan CRCKUL CRC1 cohort
Study
EGAS50000002164
-
IMMUcan CRCCLB CRC1 cohort
Study
EGAS50000002170
-
IMMUcan CRCStLuc CRC1 cohort
Study
EGAS50000002185
-
Genome-wide DNA Methylation, Transcriptomic, and Whole Exome Sequencing Data from Baseline FFPE Tumour Biopsies of Advanced Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Study
EGAS00001008432
-
Longitudinal single-cell RNA-seq data of metastatic ovarian cancer
Study
EGAS00001005006
-
GOSH_Paediatric_Tumour_23P108_WSSS_WGS_Managed_Access
Study
EGAS00001007536
-
Combination of a CCL21-gene modified dendritic cell vaccine and pembrolizumab induces immune responses in non-small cell lung cancer.
Study
EGAS50000002127
-
Prediction of benefit from adjuvant dose-dense chemotherapy for high-risk breast cancer: results from the randomized phase III PANTHER trial
Study
EGAS50000002222
-
Single cell atlas of follicular lymphoma
Study
EGAS50000002080
-
Potency-Guided Tumor-Infiltrating Lymphocyte Therapy in Metastatic Uveal Melanoma: A Phase 2 Trial
Study
phs004955
-
NCTN: Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer (CALGB-40603)
Study
phs004883
-
NCTN: A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults (AAML0531)
Study
phs004143
-
NCTN_NCORP: A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children (ACCL0431)
Study
phs004156
-
NCTN: Randomized Phase III Trial of Paclitaxel +Trastuzumab + Lapatinib Versus Paclitaxel + Trastuzumab as Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer (CALGB-40601)
Study
phs004251
-
Coupons for Healthy Intake Using Variable Economic Strategies (CHIVES-BioLINCC)
Study
phs004917
-
WGS Dataset of Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Dataset
EGAD00001015442
-
WGS/WES analysis refines molecular subtypes of hepatocellular carcinoma
Dataset
EGAD00001015428
-
SGCC GASCAD-II dataset
Dataset
EGAD00001015433
-
Geographic and age-related variations in mutational processes in colorectal cancer - patient metadata files (Mutographs)
Dataset
EGAD00001015437
-
RNA sequencing of Hepatoblastoma cell lines and drug-treated HepG2 xenograft tumors
Dataset
EGAD00001015439
-
RNA-Seq Dataset of Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Dataset
EGAD00001015441
-
GBM-Space: Spatial Transcriptomic Profiling of Glioblastoma (10x Genomics - Visium)
Dataset
EGAD00001015527
-
Citrate synthase novel variant rewires TCA cycle to promote colorectal cancer progression
Dataset
EGAD00001015543
-
RRBS data from TRACERx non-small cell lung cancer (NSCLC) tumours and matched normal adjacent tissue.
Dataset
EGAD00001015534
-
A standardised framework for robust fragmentomic feature extraction from cell-free DNA sequencing data
Dataset
EGAD00001015535
-
HCA Organoids | Colon - Cancer, Nanopore Sequencing Data
Dataset
EGAD00001015536
-
Raw molecular data for "Subclonal immune evasion in non-small cell lung cancer"
Dataset
EGAD00001015537
-
The dataset for "Validation of cfDNA fragmentome analyses for early detection of liver cancer"
Dataset
EGAD00001015538
-
HCA Organoids | Colon - Cancer, WES
Dataset
EGAD00001015548
-
Genome and transcriptome sequence data from a metastatic follicular hurtle cell carcinoma patient
Dataset
EGAD00001015550
-
Sperm sequencing reveals extensive positive selection in the human germline -WGS
Dataset
EGAD00001015592
-
Genome and transcriptome sequence data from a esophageal squamous cell carcinoma patient
Dataset
EGAD00001015556
-
Genome and transcriptome sequence data from a metastatic rectal cancer patient
Dataset
EGAD00001015557
-
Genome and transcriptome sequence data from a metastatic breast cancer patient
Dataset
EGAD00001015560